Cash · 2011–2025
Ultragenyx Pharmaceutical cash
$421M+142.0% · FY2025
Ultragenyx Pharmaceutical (RARE) reported $421M in cash for fiscal 2025, +142.0% year on year.
| Fiscal year | Cash | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $421M | +142.0% | Open → |
| FY20242024-12-31 | $174M | −18.7% | Open → |
| FY20232023-12-31 | $214M | +61.0% | Open → |
| FY20222022-12-31 | $133M | −56.8% | Open → |
| FY20212021-12-31 | $308M | −56.9% | Open → |
| FY20202020-12-31 | $714M | +64.6% | Open → |
| FY20192019-12-31 | $434M | +282.2% | Open → |
| FY20182018-12-31 | $113M | +12.9% | Open → |
| FY20172017-12-31 | $100M | −37.6% | Open → |
| FY20162016-12-31 | $161M | +72.2% | Open → |
| FY20152015-12-31 | $93.6M | +284.7% | Open → |
| FY20142014-12-31 | $24.3M | +227.5% | Open → |
| FY20132013-12-31 | $7.4M | −91.4% | Open → |
| FY20122012-12-31 | $86.2M | +709.7% | Open → |
| FY20112011-12-31 | $10.6M | — | Open → |
Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +30.0%
Cash at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Ultragenyx Pharmaceutical cash |url=https://companiesranked.com/en/company/ultragenyx-pharmaceutical/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Ultragenyx Pharmaceutical cash. CompaniesRanked. https://companiesranked.com/en/company/ultragenyx-pharmaceutical/cash-on-handBibTeX
@misc{companiesranked-en-company-ultragenyx-pharmaceutical-cash-on-hand-2026,
author = {{CompaniesRanked}},
title = {{Ultragenyx Pharmaceutical cash}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/ultragenyx-pharmaceutical/cash-on-hand}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001193125-26-333233 · August 5, 2026
{{cite web |title=Ultragenyx Pharmaceutical cash — 10-Q (0001193125-26-333233) |url=https://www.sec.gov/Archives/edgar/data/1515673/000119312526333233/rare-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-05}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.